Condition
Sham-controlled
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Recruiting1
Terminated1
Completed1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07626645Not ApplicableRecruiting
Extracorporeal Shock Wave Therapy in Lower Extremity Lymphedema
NCT07777991Not ApplicableNot Yet RecruitingPrimary
Stimulation Evaluation for Neuromodulation Sensory Effects
NCT06783361Not ApplicableCompleted
Accelerated Transcranial Magnetic Stimulation in Treatment-Resistant Depressed Patients
NCT03237754Not ApplicableTerminated
Neurostimulation in Chronic and Episodic Migraine
Showing all 4 trials